36 related articles for article (PubMed ID: 20859850)
21. Primer: establishing a clinical trial unit - regulations and infrastructure.
Fleischmann R
Nat Clin Pract Rheumatol; 2007 Apr; 3(4):234-9. PubMed ID: 17396109
[TBL] [Abstract][Full Text] [Related]
22. Does your clinical investigator understand the consequences of non-compliance?
Donato BJ; Gibson TR
Qual Assur; 1999; 7(3):135-45. PubMed ID: 11033739
[TBL] [Abstract][Full Text] [Related]
23. Joint recommendations on cost calculation and estimation in paediatric clinical trials.
Ahne G; Nagel J; Franz AR; Neubert A; Schachtrup K; Helms S; Klammt S; Schwab M
Ger Med Sci; 2024; 22():Doc04. PubMed ID: 38774559
[TBL] [Abstract][Full Text] [Related]
24. Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
Bergmann L; Berns B; Dalgleish AG; von Euler M; Hecht TT; Lappin GL; Reed N; Palmeri S; Smyth J; Embacher-Aichorn S; Zwierzina H;
Ann Oncol; 2010 Aug; 21(8):1573-1578. PubMed ID: 20133383
[TBL] [Abstract][Full Text] [Related]
25. The role of the principal investigator in cancer clinical trials.
Leong SP
Cancer Treat Res; 2007; 132():157-77. PubMed ID: 17305021
[TBL] [Abstract][Full Text] [Related]
26. Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
Herfarth HH; Jackson S; Schliebe BG; Martin C; Ivanova A; Anton K; Sandler RS; Long MD; Isaacs KL; Osterman MT; Sands BE; Higgins PD; Lewis JD
Inflamm Bowel Dis; 2017 Jan; 23(1):14-22. PubMed ID: 27598744
[TBL] [Abstract][Full Text] [Related]
27. Central statistical monitoring of investigator-led clinical trials in oncology.
Buyse M; Trotta L; Saad ED; Sakamoto J
Int J Clin Oncol; 2020 Jul; 25(7):1207-1214. PubMed ID: 32577951
[TBL] [Abstract][Full Text] [Related]
28. [Effects of the 12th amendment to the German drug code on investigator-initiated clinical trials].
Kehrel U
Gesundheitswesen; 2011 Oct; 73(10):696-701. PubMed ID: 20859850
[TBL] [Abstract][Full Text] [Related]
29. The clinician as investigator: participating in clinical trials in the practice setting.
Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
Circulation; 2004 Jun; 109(21):2672-9. PubMed ID: 15173050
[TBL] [Abstract][Full Text] [Related]
30. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
31. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
[TBL] [Abstract][Full Text] [Related]
32. [Key points in the start and conduct of a clinical trial. From question to reality in an investigator-initiated clinical trial (I)].
Tur J; Escudero A; Iglesias L; Alos M; Luque L; Burguera B
Endocrinol Nutr; 2011; 58(6):291-8. PubMed ID: 21514906
[TBL] [Abstract][Full Text] [Related]
33. The development of good clinical practice in the EEC and in Germany.
Anhalt E
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
